Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

A closer look at the evidence behind devices deemed "breakthrough" by FDA.

For older adults, the longer someone stays in the emergency department, the worse the experience can get for them, with ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

RFK Jr. wants to change federal programs that helps people injured by vaccines, though he may need Congress to do so.

An experimental psychedelic therapy from the U.K. company Beckley Psytech significantly reduced symptoms of ...

A scientific message will not resonate unless viewers have clear reason to care about the issue and, more importantly, to ...

A controversial collaboration between Duke and cord blood banker Cryo-Cell could be a worrisome sign of things to come in ...

Sage Therapeutics is laying off most of its employees after announcing its planned acquisition earlier this month.

HHS will renew funding to states for cancer prevention and tracking efforts, alleviating anxieties among local officials ...

The FDA's breakthrough devices program helps the industry with faster review times, but the benefit to patients is unclear.

The U.S. Supreme Court declined to review an appeals court ruling that struck down key parts of an Oklahoma law regulating pharmacy benefit managers.